Drug intelligence / Profile preview

Shenge Powder

Development stage: Unknown
Lead developer: Nanxiang Hospital
Administration: Oral

Overview

Shenge Powder is a Traditional Chinese Medicine (TCM) formula developed by Nanxiang Hospital for the treatment of chronic heart failure. The formula is typically used as an adjunctive therapy alongside standard Western medical treatments to improve cardiac function and alleviate clinical symptoms. Its name suggests a composition primarily featuring 'Shen' (likely referring to *Radix Ginseng* or *Radix Salviae Miltiorrhizae*) and 'Ge' (*Radix Puerariae*), both of which are traditionally used in cardiovascular care to enhance blood circulation and support myocardial health. Clinical research, such as the trial registered under ChiCTR2100049790, aims to evaluate the efficacy and safety of this integrated approach in managing heart failure patients.

Other names: Shenge San

Beyond the preview

Go deeper on Shenge Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenge Powder.

Explore the full profile